ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How To Prepare An IRB Submission For A Remote eConsent Study

  IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.

• Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory Efficiency

  Maintaining efficient, effective regulatory management processes can be a significant challenge. At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.

• Reducing Risks And Accelerating Study Startup Through An eCOA Library

  Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.

• When Protocol Amendments Meet RTSM: From Headache To High-Performance

  Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.

• Reduce Workloads And Improve Insights With Crowdsource UAT

  Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

• The Hidden Cost Of Preferred Vendors

  Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.

• The Science Behind Medable's Health Economics And Outcomes Research

  Meet the team responsible for ensuring the scientific rigor and outcomes of Medable’s clinical trial platform, and uncover how they’ve been pioneering eCOA and ePRO research for decades.

• Trial Tokenization To Understand The Long Term Effectiveness Of A New COVID-19 Vaccine

  In this case study, learn why a client needed to connect to real world date sources in order to identify potential sources of data that would enable observation of COVID-19 infection rates .

• Embracing Accessibility: The Future Of Clinical Trials

  Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.

• Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

  Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.